China NMPA Product Recall - Electric bone tissue surgical tools

Stryker Instruments, through its subsidiary Stryker (Beijing) Medical Devices Co., Ltd., initiated a voluntary Class II recall of specific models and batches of its electric bone tissue surgical tools. This action, reported to the National Medical Products Administration (NMPA) on November 30, 2020, was prompted by a critical manufacturing defect. The primary concern identified was the potential for internal drill cracks, which could lead to two significant risks during surgical procedures. Firstly, there is a risk of metal fragments detaching from the cracked drill and contaminating the surgical site. Such an event could introduce foreign bodies into a patient's tissue, potentially causing complications, infection, or requiring further intervention. Secondly, the structural integrity compromise could impede or delay the intended separation function of the surgical tool, thereby disrupting the surgical workflow and potentially prolonging procedures or affecting their outcome. The recall encompasses electric bone tissue surgical tools registered under certificate number 20152041789. As a Class II recall, the NMPA's classification indicates that the product defect may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. Stryker's voluntary action underscores its commitment to patient safety and compliance with regulatory standards set forth by the NMPA. Affected customers and healthcare providers were directed to refer to the "Medical Device Recall Event Report Form" for comprehensive details on the specific models and specifications involved, facilitating the proper handling and return of the recalled instruments to mitigate potential patient risks.